While several COVID-19 vaccines have been approved to date, the constant evolution of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) receptor-binding domain (RBD) has challenged the efficacy of these vaccines.
  • News-Medical.Net
  • Jun 11, 2021

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants - News-Medical.Net

While several COVID-19 vaccines have been approved to date, the constant evolution of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) receptor-binding domain (RBD) has challenged the… [+4708 chars]

More In health